Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 2800
interventional 1865
Observational 782
Registry 153

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Device 443
Drug 431
Procedure 204
Other 181
Drug|placebo 171
Behavioral 146
Diagnostic Test 30
Device|Drug 24
Device|Procedure 22
Dietary Supplement|placebo 19
Dietary Supplement 18
Biological 15
Device|Other 14
Drug|Procedure 14
Drug|Other 13
Behavioral|Other 12
Other|Procedure 12
Radiation 12
Biological|placebo 10
Behavioral|Drug 6
Drug|Other|placebo 6
Behavioral|Procedure 4
Combination Product 4
Genetic 4
Other|placebo 3
Behavioral|Device 2
Behavioral|Drug|Other 2
Behavioral|Drug|Procedure 2
Biological|Other 2
Device|Drug|placebo 2
Device|Drug|Procedure 2
Device|placebo 2
Diagnostic Test|Other 2
Dietary Supplement|Drug 2
Drug|placebo|Procedure 2
placebo|Procedure 2
Procedure|Radiation 2
Behavioral|Biological|Drug 1
Behavioral|Dietary Supplement|Other 1
Behavioral|Drug|placebo 1
Behavioral|Genetic 1
Behavioral|Genetic|Other 1
Biological|Device|Other 1
Biological|Device|placebo 1
Biological|Other|placebo 1
Combination Product|Device 1
Combination Product|Drug|placebo 1
Device|Other|Procedure 1
Diagnostic Test|Procedure 1
Dietary Supplement|Drug|Other 1
Dietary Supplement|Drug|Other|Procedure 1
Dietary Supplement|Drug|placebo 1
Dietary Supplement|Other 1
Drug|Genetic 1
Drug|Genetic|Other 1
Drug|placebo|Radiation 1
Drug|Procedure|Radiation 1
Genetic|placebo 1
Other|Radiation 1
placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 439
NA 134
China 122
Canada 98
Korea, Republic of 92
Germany 89
United Kingdom 78
Denmark 62
Brazil 46
France 46
Japan 46
Italy 44
Switzerland 41
Netherlands 32
Norway 27
Sweden 24
Greece 21
Poland 21
Russian Federation 19
Spain 18
Belgium 16
Finland 13
United States|Canada 13
India 12
Israel 9
Taiwan 9
Austria 8
Iran, Islamic Republic of 8
Turkey 6
Australia 5
Egypt 5
Croatia 4
Czech Republic 4
Hong Kong 4
Slovenia 4
Argentina 3
Belgium|Netherlands 3
Colombia 3
Indonesia 3
Lebanon 3
Pakistan 3
Portugal 3
Belgium|Germany 2
Colombia|Italy 2
Denmark|Sweden 2
Ecuador 2
France|Germany 2
Hungary 2
Ireland 2
Italy|Switzerland 2
Jordan 2
Mexico 2
New Zealand 2
Romania 2
Thailand 2
United States|Australia 2
United States|Canada|Denmark 2
United States|Ireland|Netherlands|Sweden 2
United States|Japan 2
United States|New Zealand|Singapore 2
United States|United Kingdom 2
Argentina|Australia|Austria|Bahrain|Bangladesh|Belgium|Bulgaria|Czechia|Denmark|Estonia|France|Germany|Hungary|India|Israel|Italy|Japan|Korea, Republic of|Netherlands|North Macedonia|Poland|Saudi Arabia|Serbia|Singapore|Slovenia|Spain|Sweden|Switzerland|United Kingdom|Vietnam 1
Argentina|Austria|Belgium|Brazil|Denmark|France|Germany|Hungary|Italy|Latvia|Netherlands|Norway|Poland|Spain|Switzerland 1
Argentina|Belgium|Brazil|Hungary|Netherlands|Poland|Russian Federation|Spain 1
Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Denmark|France|Germany|Hungary|Italy|Netherlands|Poland|Portugal|Singapore|Spain|Switzerland|United Kingdom 1
Australia|Austria|Belgium|Bulgaria|France|Hong Kong|Ireland|Italy|Korea, Republic of|Latvia|Lithuania|Malaysia|Netherlands|New Zealand|Norway|Poland|Singapore|Slovakia|Spain|Sweden|Switzerland|Thailand|United Kingdom 1
Australia|Belgium|Brazil|Denmark|France|Germany|Netherlands|Poland 1
Australia|Belgium|Brazil|Germany|Netherlands|New Zealand|Poland|Switzerland 1
Australia|Belgium|Denmark|France|Germany|Netherlands|New Zealand|Portugal|Switzerland|United Kingdom 1
Australia|Belgium|Denmark|France|Netherlands|New Zealand|Poland|Switzerland 1
Australia|Belgium|Denmark|France|New Zealand|Poland|Spain|Sweden|United Kingdom 1
Australia|Belgium|New Zealand 1
Australia|Brazil|Singapore 1
Australia|France|Netherlands|Sweden|United Kingdom 1
Australia|Latvia|New Zealand 1
Australia|Malaysia|New Zealand|Singapore 1
Australia|New Zealand|Singapore 1
Austria|Belgium|China|Germany|Hong Kong|Italy|Netherlands|Portugal|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
Austria|Belgium|Denmark|France|Germany|India|Italy|Netherlands|New Zealand|Poland|South Africa|Spain|Switzerland 1
Austria|Belgium|France|Germany|Netherlands|United Kingdom 1
Austria|Belgium|Germany|Netherlands|Poland|Spain|Sweden|Switzerland 1
Austria|Belgium|United States|Argentina|Australia|Brazil|Canada|China|Czechia|Denmark|Finland|France|Germany|Grenada|Hungary|Ireland|Israel|Italy|Korea, Republic of|Netherlands|New Zealand|Poland|Puerto Rico|Slovakia|South Africa|Spain|Sweden|Switzerland|United Kingdom 1
Austria|Czechia|Denmark|Germany|Hungary|Ireland|Italy|Latvia|Lithuania|Poland|Portugal|Romania|Serbia|Spain|United Kingdom 1
Austria|Denmark|France|Germany|Greece|Netherlands|Portugal|Spain 1
Austria|Denmark|Germany|Hungary|Switzerland 1
Austria|Denmark|Germany|Switzerland 1
Austria|France|Germany|Israel|Italy|Malaysia|Netherlands|Poland|Spain|Thailand|United Kingdom 1
Austria|France|Germany|Italy|Netherlands|Switzerland|United Kingdom 1
Austria|Germany|Israel|United Kingdom 1
Austria|Germany|Switzerland 1
Austria|Hungary 1
Belgium|Brazil 1
Belgium|Brazil|Czechia|Latvia|Macedonia, The Former Yugoslav Republic of|Netherlands|Poland|Spain|United Kingdom 1
Belgium|Brazil|Denmark|Germany|Netherlands|Singapore|Spain|Switzerland 1
Belgium|Brazil|Denmark|Germany|New Zealand|Poland 1
Belgium|Czech Republic|France|Germany|Netherlands|Spain|Sweden|United Kingdom 1
Belgium|Czechia|France|Germany|Netherlands|Sweden|Switzerland 1
Belgium|Denmark|Estonia|Finland|Germany|Ireland|Italy|Latvia|Netherlands|Norway|Poland|Sweden|United Kingdom 1
Belgium|Denmark|France|Germany|Italy|Netherlands|Spain|Sweden|United Kingdom 1
Belgium|Finland|Netherlands|Switzerland|United Kingdom 1
Belgium|France|Germany|Netherlands|Poland|Switzerland|United Kingdom 1
Belgium|France|Luxembourg|Netherlands 1
Belgium|France|Netherlands|New Zealand|Sweden|United Kingdom 1
Belgium|Germany|Israel|Sweden 1
Belgium|Germany|Netherlands|Switzerland 1
Belgium|Germany|Netherlands|United Kingdom 1
Belgium|Italy 1
Belgium|Italy|Netherlands 1
Belgium|New Zealand 1
Belgium|United Kingdom 1
Brazil|Germany 1
Brazil|Indonesia|Macedonia, The Former Yugoslav Republic of|Malaysia 1
Bulgaria|United States|Argentina|Australia|Canada|Czechia|Denmark|France|Germany|Hungary|Italy|Korea, Republic of|Netherlands|Poland|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 1
Cameroon|Canada|Italy|Spain|United Kingdom| 1
Canada|Czech Republic|France|Poland|Romania|Russian Federation|Slovakia 1
Canada|New Zealand 1
Chile 1
China|Hong Kong 1
China|Korea, Republic of 1
Czechia 1
Czechia|Denmark|Germany|Switzerland 1
Czechia|Germany|Hungary|Netherlands|Norway|Poland|Singapore|Sweden 1
Czechia|United States|Australia|France|Germany|Hungary|New Zealand|Poland|Romania|United Kingdom 1
Denmark|Estonia|Finland|France|Norway|Spain|Sweden|United Kingdom 1
Denmark|Finland|Latvia|Sweden 1
Denmark|Finland|Sweden 1
Denmark|France|Germany|Italy|Japan|Lithuania|Netherlands|Poland|Spain|Sweden|Switzerland 1
Denmark|France|Germany|Italy|Latvia|Serbia|Spain|United Kingdom 1
Denmark|France|Germany|Netherlands 1
Denmark|Germany|Netherlands 1
Denmark|Italy|Japan|Netherlands|Spain|United Kingdom 1
Denmark|Latvia 1
Denmark|Netherlands|Spain 1
Denmark|Netherlands|Spain|Sweden 1
Denmark|Poland 1
Denmark|Spain 1
Finland|France|Germany|Italy|Netherlands|Poland|Spain|Switzerland|United Kingdom 1
France|Germany|Italy|Netherlands 1
France|Germany|Italy|Serbia|Spain 1
France|Germany|Italy|Spain|Switzerland 1
France|Germany|Netherlands 1
France|Netherlands|United Kingdom 1
Germany|Italy|Jordan 1
Germany|Jordan|Spain 1
Germany|Latvia 1
Germany|Moldova, Republic of|Netherlands 1
Germany|Switzerland 1
Germany|United Kingdom 1
Greece|Hungary|Ireland|Poland|Portugal|Russian Federation|Slovakia|Switzerland| 1
Hong Kong|Taiwan 1
Hungary|Netherlands 1
Ireland|Austria|Belgium|Canada|China|Czech Republic|France|Germany|Greece|India|Israel|Italy|Malaysia|Netherlands|New Zealand|Portugal|Singapore|South Africa|Spain|Sweden|Switzerland|Thailand|United Kingdom 1
Ireland|United Kingdom 1
Israel|Netherlands|South Africa|United States|Belgium|Denmark|United Kingdom 1
Italy|Netherlands 1
Italy|Spain 1
Italy|United Kingdom 1
Japan|Philippines 1
Japan|Poland|Portugal|Ukraine|United States|Argentina|Australia|Brazil|Bulgaria|Canada|China|Czechia|Denmark|Estonia|France|Germany|Greece|Hungary|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Romania|Russian Federation|Slovakia|South Africa|Spain|Sweden|Turkey|United Kingdom 1
Kazakhstan 1
Latvia 1
Lithuania 1
Malaysia 1
Netherlands|Russian Federation 1
Netherlands|Spain 1
Netherlands|Switzerland 1
Norway|United States|Australia|Belgium|Canada|Czechia|Denmark|France|Hungary|Korea, Republic of|Lithuania|Netherlands|New Zealand|Serbia|Sweden|United Kingdom 1
Oman 1
Palestinian Territory, occupied 1
Poland|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Denmark|France|Germany|India|Israel|Italy|Japan|Malaysia|Netherlands|New Zealand|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
Poland|United Kingdom 1
Portugal|Argentina|Australia|Austria|Belgium|Brazil|China|Denmark|France|Germany|Greece|Hungary|India|Israel|Italy|Latvia|Malaysia|Netherlands|Norway|Poland|Russian Federation|South Africa|Spain|Switzerland|United Kingdom|Venezuela 1
Slovakia 1
South Africa 1
Spain|United States|Australia|Austria|Belgium|Canada|France|Germany|Ireland|Italy|Netherlands|South Africa|Switzerland|United Kingdom| 1
Sri Lanka 1
Trinidad and Tobago 1
Ukraine 1
United States|Argentina 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|China|Croatia|Czech Republic|Estonia|Finland|France|Germany|Greece|India|Ireland|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Poland|Romania|Russian Federation|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Egypt|France|Germany|Hungary|India|Israel|Italy|Japan|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|North Macedonia|Peru|Poland|Portugal|Romania|Russian Federation|Saudi Arabia|Serbia|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|Czech Republic|France|India|Korea, Republic of|Mexico|Netherlands|Poland|Portugal|Russian Federation|Spain|Turkey 1
United States|Argentina|Australia|Belgium|Brazil|Canada|France|Hungary|Italy|Mexico|Netherlands|Poland|Russian Federation|Spain 1
United States|Argentina|Australia|Belgium|Canada|France|Germany|Hungary|Italy|Poland|Spain 1
United States|Argentina|Australia|Bulgaria|Canada|Denmark|Estonia|France|Germany|Hungary|India|Netherlands|New Zealand|Pakistan|Romania|Spain 1
United States|Argentina|Brazil|Canada|Finland 1
United States|Argentina|Brazil|Chile|Colombia|Lithuania|Netherlands|Peru|Venezuela 1
United States|Argentina|Peru|Puerto Rico 1
United States|Australia|Austria|Belgium|Canada|Denmark|Finland|France|Italy|Japan|Latvia|Netherlands|New Zealand|Poland|Singapore|Spain 1
United States|Australia|Austria|Belgium|Denmark|Finland|France|Germany|Japan|Latvia|Malaysia|Netherlands|New Zealand|Poland|Portugal|Singapore|United Kingdom 1
United States|Australia|Belgium|Canada|Denmark|Germany|Hungary|Israel|Korea, Republic of|Netherlands|New Zealand|Spain|Switzerland 1
United States|Australia|Belgium|Canada|France|Italy|Netherlands|Poland|Spain 1
United States|Australia|Belgium|Canada|France|Italy|Netherlands|Spain 1
United States|Australia|Belgium|Denmark|France|Germany|Italy|Netherlands|New Zealand|Portugal|Spain|United Kingdom 1
United States|Australia|Belgium|Egypt|Finland|Germany|Italy|Japan|Korea, Republic of|Latvia|Netherlands|Portugal|Saudi Arabia|South Africa|Spain|Turkey|United Kingdom 1
United States|Australia|Belgium|France|Japan|Latvia|New Zealand 1
United States|Australia|Belgium|France|Japan|New Zealand 1
United States|Australia|Canada|China|Czech Republic|Denmark|France|Hungary|Mexico|Netherlands|Poland|Spain|United Kingdom 1
United States|Australia|Canada|China|New Zealand|Singapore|Taiwan 1
United States|Australia|Canada|Germany 1
United States|Australia|Canada|Singapore 1
United States|Australia|China|Italy|Japan|Korea, Republic of|New Zealand|Singapore|Taiwan 1
United States|Australia|Czechia|Germany|Hungary|Italy|Netherlands 1
United States|Australia|Germany|New Zealand 1
United States|Australia|Malaysia|New Zealand 1
United States|Australia|New Zealand|Singapore 1
United States|Austria|Belgium|Canada|Czech Republic|France|Germany|Israel|Italy|Netherlands|Poland|Russian Federation|Spain|Sweden|United Kingdom 1
United States|Austria|Belgium|Canada|Germany|Switzerland 1
United States|Austria|Canada|China|Croatia|Germany|Italy|Japan|Korea, Republic of|Netherlands|Portugal|Serbia|Singapore 1
United States|Austria|Canada|Germany|Spain|United Kingdom 1
United States|Belarus|Bulgaria|Canada|Czech Republic|Georgia|Germany|Israel|Poland|Russian Federation|Serbia|Slovakia|Slovenia|Ukraine 1
United States|Belgium|Canada|Czechia|Denmark|France|Germany|Hungary|Italy|Netherlands|Serbia|Sweden|United Kingdom 1
United States|Belgium|Canada|Japan|Netherlands|Spain|Switzerland|United Kingdom 1
United States|Belgium|Canada|Netherlands|Poland|Spain 1
United States|Belgium|France|Germany|Latvia|Netherlands|Spain 1
United States|Belgium|Germany|Italy|Japan|Netherlands|Spain|United Kingdom 1
United States|Belgium|Israel|Spain 1
United States|Brazil 1
United States|Brazil|Canada|Denmark|Germany|Japan|Netherlands|Singapore 1
United States|Brazil|Germany|Japan|Latvia|Sweden|Switzerland 1
United States|Brazil|India|Italy|Korea, Republic of|Poland 1
United States|Canada|China|Germany|India|Japan|Taiwan 1
United States|Canada|Czech Republic|Germany|Hungary|New Zealand|Norway|Slovakia|South Africa 1
United States|Canada|Czech Republic|Germany|South Africa|United Kingdom 1
United States|Canada|Denmark|Netherlands|Singapore|Sweden|United Kingdom 1
United States|Canada|Denmark|United Kingdom 1
United States|Canada|Finland|France|Germany|Netherlands 1
United States|Canada|Finland|Puerto Rico 1
United States|Canada|Germany|United Kingdom 1
United States|Canada|India 1
United States|Canada|Korea, Republic of|Mexico 1
United States|Colombia 1
United States|Colombia|Germany|Latvia|Netherlands 1
United States|Czechia|Netherlands|United Kingdom 1
United States|Denmark|Germany|Israel|Netherlands 1
United States|France|Germany|Israel 1
United States|France|Germany|Korea, Republic of|New Zealand|Switzerland|United Kingdom 1
United States|France|Germany|Netherlands 1
United States|France|Germany|United Kingdom 1
United States|Germany 1
United States|Germany|Ireland 1
United States|India 1
United States|Latvia|New Zealand|United Kingdom 1
United States|Netherlands 1
United States|New Zealand|Singapore|Taiwan 1
United States|Puerto Rico 1
United States|Ukraine 1
Venezuela 1

Sites per Study

Site_count Study_Count
1 1316
2 108
3 49
4 34
5 35
6 28
7 14
8 14
9 17
10 17
11 9
12 17
13 14
14 8
15 13
16 9
17 12
18 6
19 4
20 6
21 1
23 5
24 3
25 8
26 3
27 5
28 7
29 3
30 3
32 2
33 3
34 4
35 2
36 2
37 2
38 2
39 3
41 3
44 1
45 1
46 3
48 2
49 1
50 3
51 3
52 3
53 1
54 1
56 1
58 2
59 1
60 1
61 1
62 3
64 1
65 2
69 1
73 1
74 1
81 1
82 1
86 2
89 1
90 1
92 2
93 1
95 1
102 1
110 1
112 1
119 1
120 1
121 1
122 1
124 1
126 1
128 1
130 1
133 1
135 1
138 1
144 1
147 1
150 1
154 1
177 1
188 1
195 2
218 1
241 1
256 1
314 1
320 1
471 1
578 1
1091 1

Phase

Phase Study_Count
N/A 894
Phase 4 417
Phase 3 227
Phase 2 173
Phase 1 67
Phase 2/Phase 3 47
Phase 1/Phase 2 30
Early Phase 1 10

Number of Arms

Number_of_Arms Count_of_Studies
1 333
2 1068
3 170
4 67
5 6
6 15
8 2
11 1
NA 203

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 20.00 1.0000 5.0000 10.0000 2.0000 18.0000 20.000 11.0000
1st Qu. 24.00 60.0000 15.5000 29.2500 35.0000 59.5000 100.000 62.0000
Median 39.00 137.0000 32.0000 56.5000 79.0000 120.0000 281.000 179.0000
Mean 45.20 568.1757 177.0299 115.5667 193.0643 292.9149 1244.472 870.4747
3rd Qu. 49.75 412.5000 64.0000 134.7500 150.0000 319.0000 769.250 634.5000
Max. 92.00 61301.0000 8400.0000 643.0000 10000.0000 3043.0000 25673.000 25682.0000

Trial Group Type

group_type Group_Count
Experimental 1541
Active Comparator 1092
Placebo Comparator 292
Other 227
No Intervention 221
NA 203
Sham Comparator 21

Intervention Model

intervention_model Study_Count
Parallel Assignment 1218
Single Group Assignment 452
Crossover Assignment 109
Factorial Assignment 45
NA 24
Sequential Assignment 17

Primary Purpose

primary_purpose Study_Count
Treatment 1151
Diagnostic 235
Prevention 210
Basic Science 70
Supportive Care 51
Health Services Research 48
Other 44
NA 38
Screening 16
Device Feasibility 1
Educational/Counseling/Training 1

Observational Studies

Studies by Country

Country Study_Count
United States 186
NA 124
Korea, Republic of 52
Germany 41
China 39
United Kingdom 29
Canada 28
France 18
Italy 18
Netherlands 18
Denmark 15
Switzerland 14
Japan 12
Brazil 11
Norway 11
Israel 10
Singapore 9
Sweden 9
Finland 8
Poland 8
Austria 7
Belgium 7
Greece 7
India 6
Russian Federation 6
Turkey 6
Spain 4
United States|Canada 4
Croatia 3
Egypt 3
Taiwan 3
Hong Kong 2
Iran, Islamic Republic of 2
Romania 2
United States|Denmark 2
Argentina|Belgium|Brazil|Denmark|Finland|France|Germany|Greece|Italy|Luxembourg|Mexico|Netherlands|Norway|Poland|Romania|Slovenia|Spain|Turkey|United Kingdom|Venezuela 1
Argentina|Norway 1
Australia 1
Austria|Bangladesh|Belarus|Brazil|Bulgaria|Chile|Czechia|Denmark|Egypt|Estonia|France|Georgia|Germany|Hungary|Indonesia|Ireland|Israel|Latvia|Lithuania|Malta|Mexico|Netherlands|Poland|Romania|Russian Federation|Serbia|Slovenia|Spain|Sweden|Taiwan|Ukraine|United Kingdom 1
Austria|Belgium|Denmark|France|Germany|Hungary|Ireland|Italy|Netherlands|Spain|United Kingdom 1
Austria|Czechia|Denmark|France|Germany|Ireland|Jordan|Latvia|Lithuania|Morocco|Poland|Portugal|Russian Federation|Spain|Switzerland|United Kingdom 1
Austria|Germany 1
Bangladesh 1
Belgium|Bulgaria|Croatia|Czechia|Denmark|Finland|Germany|Greece|Hungary|Netherlands|Poland|Slovakia|Spain|Sweden|Switzerland|United Kingdom 1
Belgium|Denmark|United States|Israel 1
Belgium|France 1
Belgium|France|Germany|Hungary|Ireland|Italy|Latvia|Poland|Spain|United Kingdom 1
Belgium|France|Germany|Italy|Switzerland 1
Belgium|Germany|Italy|Switzerland 1
Belgium|Singapore 1
Belgium|Sweden|United Kingdom 1
Brazil|Germany|Italy|United Kingdom 1
Bulgaria 1
China|India|Korea, Republic of|Singapore 1
China|India|Malaysia|Sri Lanka|Vietnam 1
China|Korea, Republic of|Malaysia|Taiwan|Thailand 1
Denmark|France|Germany|Italy|Japan|Netherlands|United Kingdom 1
Denmark|Netherlands|New Zealand|Poland 1
Ecuador 1
Germany|Hungary 1
Germany|Italy|Portugal|Spain 1
Germany|Malaysia|Spain 1
Germany|Poland 1
Hungary 1
Italy|Austria|Belgium|Bulgaria|Germany|Netherlands|Poland|Switzerland|United Kingdom 1
Pakistan 1
Paraguay 1
Portugal 1
Portugal|Spain 1
Qatar 1
Slovenia 1
Spain|Sweden 1
Spain|Switzerland|United Kingdom 1
Spain|United Kingdom 1
Spain|United States|Belgium|Denmark|France|Germany|Italy|Netherlands|Poland|Sweden|Switzerland|United Kingdom 1
Trinidad and Tobago 1
United States|Australia|Austria|Belgium|Canada|China|Czechia|France|Germany|Italy|Japan|Netherlands|Spain|United Kingdom 1
United States|Austria|Belgium|Denmark|France|Germany|Italy|United Kingdom 1
United States|Austria|Canada|Egypt|Estonia|Germany|Greece|India|Italy|Japan|Netherlands|Portugal|Saudi Arabia|Spain|United Kingdom 1
United States|Austria|Canada|Germany|Italy|Korea, Republic of|Switzerland 1
United States|Belgium|Czech Republic|Netherlands|Sweden 1
United States|Belgium|France|Italy|Korea, Republic of|Netherlands|Portugal|Sweden|United Kingdom 1
United States|Belgium|France|Slovakia 1
United States|Bulgaria 1
United States|Canada|China|Italy|Japan|Korea, Republic of|Latvia|Netherlands 1
United States|Canada|Puerto Rico 1
United States|Canada|Switzerland 1
United States|Denmark|France|Italy|Latvia|Netherlands|Poland|United Kingdom 1
United States|France|Germany|Italy|Japan|Netherlands 1
United States|Germany|Ireland|Japan|Netherlands|Spain|United Kingdom 1
United States|Italy|Latvia|Netherlands|Slovakia|United Kingdom 1
United States|Netherlands|United Kingdom 1
United States|Saudi Arabia 1

Sites per Study

Site_count Study_Count
1 600
2 38
3 15
4 14
5 10
6 10
7 3
8 7
9 6
10 8
11 4
12 3
13 3
14 1
15 2
16 1
17 1
18 4
19 3
20 4
21 1
22 1
23 4
24 3
25 1
26 1
28 2
29 3
33 2
34 1
36 1
37 1
38 1
40 4
41 1
42 2
43 1
44 1
47 1
50 2
58 1
68 1
69 1
71 1
81 1
82 1
90 1
107 1
183 1
257 1
411 1

Enrollment Metrics

Measure Observational
Min 1.00
1st Qu 96.75
Median 300.00
Mean 6364.31
3rd Qu 1107.75
Max 1758584.00

Observation Model

observational_model Study_Count
Cohort 450
Case-Only 94
NA 86
Case-Control 43
Case Control 43
Other 43
Case-Crossover 7
Defined Population 4
Defined Population, Natural History 4
Ecologic or Community 4
Family-Based 2
Case Control, Natural History 1
Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 540
Retrospective 99
Cross-Sectional 67
NA 53
Other 12
Longitudinal, Prospective 6
Cross-Sectional, Prospective 2
Cross-Sectional, Retrospective 1
Longitudinal, Retrospective 1
Longitudinal, Retrospective/Prospective 1

Registries

Studies by Country

Country Study_Count
China 19
Korea, Republic of 17
United States 15
Italy 13
Spain 9
Germany 8
Netherlands 7
Belgium 5
Japan 5
NA 5
Greece 4
Brazil 3
Russian Federation 3
France 2
Singapore 2
Switzerland 2
United Kingdom 2
Argentina|Armenia|Austria|Bangladesh|Belarus|Belgium|Brazil|Bulgaria|Chile|Colombia|Czechia|Egypt|Estonia|France|Georgia|Hungary|Iceland|India|Indonesia|Ireland|Israel|Japan|Jordan|Kazakhstan|Kuwait|Lebanon|Lithuania|Malaysia|Mexico|Morocco|Netherlands|North Macedonia|Oman|Poland|Portugal|Romania|Saudi Arabia|Serbia|Slovakia|South Africa|Spain|Sweden|Switzerland|Thailand|Tunisia|Ukraine|United Arab Emirates|United Kingdom|Uzbekistan|Vietnam 1
Australia|Germany|United Kingdom 1
Austria|Germany|Ireland|Italy|Spain|Switzerland|Turkey|United Kingdom 1
Belgium|Canada|Germany|Japan|Singapore 1
Belgium|Hong Kong 1
Belgium|Netherlands 1
Canada 1
Denmark|Norway 1
Egypt 1
Finland 1
France|Germany|Italy|Spain 1
France|Germany|Switzerland 1
Germany|Malaysia|Spain 1
India 1
Indonesia 1
Israel 1
Mexico 1
Netherlands|Poland|Spain|United Kingdom 1
Netherlands|Russian Federation 1
Norway 1
Poland 1
Portugal 1
Spain|Portugal 1
Sweden 1
Thailand 1
Tunisia 1
Turkey 1
United States|Argentina|Canada|India|Italy 1
United States|Canada|Egypt|Greece|Lebanon|Russian Federation 1
United States|Canada|Germany|Israel 1
United States|India|Singapore 1
United States|Israel 1

Sites per Study

Site_count Study_Count
1 93
2 5
3 6
4 8
5 2
6 4
7 4
8 1
9 2
11 2
13 1
14 2
15 1
16 3
17 1
18 1
19 1
20 1
21 1
22 1
24 1
26 1
28 1
31 1
36 1
37 3
44 1
48 1
52 1
54 1
462 1

Enrollment Metrics

Measure Registries
Min 28.00
1st Qu 300.00
Median 1000.00
Mean 90799.25
3rd Qu 2275.00
Max 7205000.00

Registry Model

observational_model Study_Count
Cohort 108
Case-Only 24
Other 14
Case-Control 6
Case-Crossover 1

Time Perspective

time_perspective Study_Count
Prospective 139
Other 6
Cross-Sectional 5
NA 2
Retrospective 1

Follow-up

target_duration Study_Count
5 Years 33
12 Months 24
1 Year 18
3 Years 13
2 Years 12
1 Day 11
24 Months 7
10 Years 6
1 Month 4
6 Months 4
18 Months 3
3 Days 3
9 Months 3
1 Week 2
3 Months 2
1095 Days 1
12 Weeks 1
17 Years 1
2 Days 1
30 Days 1
36 Months 1
7 Days 1
90 Days 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03227588 Evaluation of the Opsens Fractional Flow Reserve (FFR) Wire as a “Work Horse” Wire https://ClinicalTrials.gov/show/NCT03227588 Recruiting Central Arkansas Veterans Healthcare System 2019-12-10
NCT04298307 Registry of Coronary Lithotripsy in Spain. https://ClinicalTrials.gov/show/NCT04298307 Recruiting Fundación EPIC 2022-06-01
NCT04138238 Cruz HBR Registry - Post-market Registry to Evaluate the Safety and Efficacy of the Supraflex Cruz Stent https://ClinicalTrials.gov/show/NCT04138238 Recruiting Sahajanand Medical Technologies Pvt. Ltd. 2021-11-30
NCT03373552 Genetic Polymorphism Contributing to the Variability of Clopidogrel Response in Patients With Coronary Artery Disease https://ClinicalTrials.gov/show/NCT03373552 Recruiting Hôpital Universitaire Fattouma Bourguiba 2019-11-15
NCT03479580 Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry https://ClinicalTrials.gov/show/NCT03479580 Recruiting University Hospital, Grenoble 2028-02-29
NCT03824600 Physiological Patterns of Coronary Artery Disease https://ClinicalTrials.gov/show/NCT03824600 Completed Onze Lieve Vrouw Hospital 2019-08-30
NCT03327961 Scaffold in Emilia Romagna and in the MAGIC Network https://ClinicalTrials.gov/show/NCT03327961 Recruiting University Hospital of Ferrara 2021-12-31
NCT03326778 Registry to Gather Long-time Results After Surgical Aortic Valve Replacement With a "Rapid Deployment Aortic Valve Prothesis (Edwards Intuity) Combined With Bypss Surgery (CABG) https://ClinicalTrials.gov/show/NCT03326778 Recruiting Campus Bad Neustadt 2019-07-31
NCT03315234 Correlation of Genetic Polymorphisms and Clinical Parameters With the Complexity of Coronary Artery Disease https://ClinicalTrials.gov/show/NCT03315234 Active, not recruiting Aristotle University Of Thessaloniki 2018-06-30
NCT03312179 STEMI and Incretins Treatment https://ClinicalTrials.gov/show/NCT03312179 Completed University of Campania “Luigi Vanvitelli” 2017-09-01
NCT03278301 PRECISION GRX Registry https://ClinicalTrials.gov/show/NCT03278301 Completed Corindus Inc. 2020-02-06
NCT03273023 PROMUS PREMIERâ„¢ China Post-Approval Study https://ClinicalTrials.gov/show/NCT03273023 Active, not recruiting Boston Scientific Corporation 2020-06-30
NCT03263260 Post-marketing Registry of Inspiron Sirolimus Eluting Coronary Stent https://ClinicalTrials.gov/show/NCT03263260 Recruiting Scitech Produtos Medicos Ltda 2021-12-30
NCT03151018 Effect and Efficacy of Onyxâ„¢, Zotarolimus-eluting Stent for Coronary Atherosclerosis https://ClinicalTrials.gov/show/NCT03151018 Recruiting Seoul National University Hospital 2018-05-31
NCT03150680 Development of a Risk Prediction Algorithm Through the Investigation of Genetic Risk Factors and the Complexity of Coronary Artery Disease to Estimate Future Risk of Cardiovascular Events: Angiographic (SYNTAX Score), Clinical and Pharmacogenetic Analysis. https://ClinicalTrials.gov/show/NCT03150680 Recruiting AHEPA University Hospital 2020-02-29
NCT03129503 Optical Coherence Tomography in Acute Coronary Syndrome https://ClinicalTrials.gov/show/NCT03129503 Active, not recruiting Charite University, Berlin, Germany 2024-03-31
NCT03085823 The All-comers Sirolimus-coated Balloon European Registry https://ClinicalTrials.gov/show/NCT03085823 Recruiting Fatebenefratelli and Ophthalmic Hospital 2020-12-31
NCT03066141 Evaluation of Association Between Obstructive Sleep Apnea and the Severity of Coronary Artery Disease https://ClinicalTrials.gov/show/NCT03066141 Completed Chinese Pulmonary Vascular Disease Research Group 2019-08-29
NCT03051061 Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation https://ClinicalTrials.gov/show/NCT03051061 Recruiting Henan Institute of Cardiovascular Epidemiology 2019-12-01
NCT03049995 Stress Echo 2020 - The International Stress Echo Study https://ClinicalTrials.gov/show/NCT03049995 Recruiting Fatebenefratelli Hospital 2020-12-31
NCT03045913 Genoss DES Prospective Multicenter Registry https://ClinicalTrials.gov/show/NCT03045913 Recruiting Yonsei University 2019-12-31
NCT03030495 Registry of Comprehensive Imaging and Physiological Evaluation of Deferred Lesions Based on FFR https://ClinicalTrials.gov/show/NCT03030495 Recruiting Samsung Medical Center 2022-12-31
NCT02996903 Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017 https://ClinicalTrials.gov/show/NCT02996903 Completed Klinikum der Universitaet Muenchen 2017-10-31
NCT02989740 Optical Coherence Tomography Morphologic and Fractional Flow Reserve Assessment in Diabetes Mellitus Patients https://ClinicalTrials.gov/show/NCT02989740 Active, not recruiting Diagram B.V. 2020-06-30
NCT02996877 Outcomes of Surgically Ineligible Patients With Multivessel CAD https://ClinicalTrials.gov/show/NCT02996877 Active, not recruiting Saint Luke’s Health System 2020-06-30
NCT02986295 Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent https://ClinicalTrials.gov/show/NCT02986295 Recruiting Samsung Medical Center 2019-01-31
NCT02966262 Korea University Anam Hospital Optical Coherence Tomography Registry https://ClinicalTrials.gov/show/NCT02966262 Recruiting Korea University Anam Hospital 2019-12-31
NCT02922088 EU Multicenter Registry to Assess Outcomes in CABG Patients: Treatment of Vascular Conduits With DuraGraft [VASC] https://ClinicalTrials.gov/show/NCT02922088 Active, not recruiting Somahlution LLC 2024-08-31
NCT02888652 Study on the Registration of Coronary Heart Disease Patients Undergoing PCI https://ClinicalTrials.gov/show/NCT02888652 Completed The Third Xiangya Hospital of Central South University 2018-08-31
NCT02858739 Biofreedom Stent in All Comer Population https://ClinicalTrials.gov/show/NCT02858739 Completed University of Roma La Sapienza 2016-05-31
NCT02854813 Overactive Bladder in Elderly Patients- An Early Warning of Coronary Artery Disease https://ClinicalTrials.gov/show/NCT02854813 Completed Ankara Training and Research Hospital 2017-01-31
NCT02845804 Effect and Efficacy of Xpeditionâ„¢/Alpineâ„¢, Everolimus-eluting Stent for Coronary Atherosclerosis https://ClinicalTrials.gov/show/NCT02845804 Recruiting Seoul National University Hospital 2018-07-31
NCT02817802 BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IV https://ClinicalTrials.gov/show/NCT02817802 Recruiting Biotronik AG 2020-10-31
NCT02803411 Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging(PARADIGM) https://ClinicalTrials.gov/show/NCT02803411 Active, not recruiting Yonsei University 2026-01-31
NCT02789943 Multi- Level and Integrated Analysis of Mechanisms Underlying Atrial Dysfunction https://ClinicalTrials.gov/show/NCT02789943 Recruiting National Heart Centre Singapore 2017-07-31
NCT02751060 Evaluation of Plasma Non-coding RNAs as Biomarkers in Coronary Heart Disease https://ClinicalTrials.gov/show/NCT02751060 Enrolling by invitation Tongji Hospital 2019-12-31
NCT02737982 Sex and Gender Differences in Ischemic Heart Disease - Endocrine Vascular Disease Approach https://ClinicalTrials.gov/show/NCT02737982 Recruiting University of Roma La Sapienza 2019-12-31
NCT02693158 The Direct III Post Market Study https://ClinicalTrials.gov/show/NCT02693158 Completed Svelte Medical Systems, Inc. 2019-01-31
NCT02692833 Telomere Biology and AKI in Cardiac Surgery https://ClinicalTrials.gov/show/NCT02692833 Completed Queen Mary University of London 2017-05-31
NCT02635230 What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2. https://ClinicalTrials.gov/show/NCT02635230 Recruiting R&D Cardiologie 2021-01-31
NCT02629575 Coroflex ISAR 2000 Registry https://ClinicalTrials.gov/show/NCT02629575 Completed B. Braun Melsungen AG 2016-12-31
NCT02621216 Tilburg Health Outcomes Registry of Emotional Stress in Coronary Intervention https://ClinicalTrials.gov/show/NCT02621216 Recruiting University of Tilburg 2023-12-31
NCT02042300 XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT02042300 Active, not recruiting Asan Medical Center 2020-05-31
NCT02038127 Gangwon PCI Registry https://ClinicalTrials.gov/show/NCT02038127 Recruiting Yonsei University 2020-12-31
NCT02565615 Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting https://ClinicalTrials.gov/show/NCT02565615 Completed Pfizer 2018-08-31
NCT02554292 Post Market Surveillance of SeQuent Please Neo With Scoring Balloon https://ClinicalTrials.gov/show/NCT02554292 Completed B. Braun Melsungen AG 2018-12-31
NCT02499679 Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care https://ClinicalTrials.gov/show/NCT02499679 Completed HeartFlow, Inc. 2019-02-28
NCT02486315 Treatment of Coronary ARtery bIfurcation Narrowing by AXxess Stent Implantation https://ClinicalTrials.gov/show/NCT02486315 Completed Clinica Mediterranea 2014-08-31
NCT02440646 Natural History of Atherosclerosis in Real-World Patients Underwent Computed Tomography Angiography https://ClinicalTrials.gov/show/NCT02440646 Enrolling by invitation Ural Medical University 2016-12-31
NCT02407197 International T1 Multicentre CMR Outcome Study https://ClinicalTrials.gov/show/NCT02407197 Active, not recruiting King’s College London 2017-12-31
NCT02406326 An Evaluation of BioMimeâ„¢ - Sirolimus Eluting Coronary Stent in a Multi- Centre Study. https://ClinicalTrials.gov/show/NCT02406326 Completed Meril Life Sciences Pvt. Ltd. 2016-12-27
NCT02410330 Therapeutic Use of Ultrasound in Acute Coronary Artery Disease https://ClinicalTrials.gov/show/NCT02410330 Completed University of Sao Paulo General Hospital 2020-01-31
NCT02396186 An Assessment of the Glider Balloon in Complex Lesions https://ClinicalTrials.gov/show/NCT02396186 Completed TriReme Medical, LLC 2017-06-30
NCT02364778 Single-centre, Registry Trial, the Patients Presented With Stable Coronary Artery Disease https://ClinicalTrials.gov/show/NCT02364778 Completed Icahn School of Medicine at Mount Sinai 2015-05-31
NCT02362659 Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry https://ClinicalTrials.gov/show/NCT02362659 Completed Icahn School of Medicine at Mount Sinai 2018-11-15
NCT02360709 Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Artery Lesions https://ClinicalTrials.gov/show/NCT02360709 Recruiting CID S.p.A. 2017-01-31
NCT02341664 Patient and Provider Assessment of Lipid Management Registry https://ClinicalTrials.gov/show/NCT02341664 Completed Duke University 2016-02-29
NCT02313038 Prospective Assessment of Efficacy and Safety of Drug Eluting Stents https://ClinicalTrials.gov/show/NCT02313038 Completed China National Center for Cardiovascular Diseases 2015-07-31
NCT02298413 Italian Absorb Registry https://ClinicalTrials.gov/show/NCT02298413 Active, not recruiting Ospedale Santa Croce-Carle Cuneo 2016-11-30
NCT02281110 The REAL Registry for Utilization of iFR in Assessing Coronary Stenoses https://ClinicalTrials.gov/show/NCT02281110 Completed Volcano Corporation 2015-12-31
NCT02247492 BIOFLOW-III VIP Russia Registry Orsiro Stent System https://ClinicalTrials.gov/show/NCT02247492 Recruiting Biotronik Russia 2019-04-30
NCT02240810 PLATINUM Diversity https://ClinicalTrials.gov/show/NCT02240810 Completed Boston Scientific Corporation 2016-09-30
NCT02191306 Utilizing Computed Tomographic Angiography to Evaluate Coronary Artery Disease in Patients on Long-Term Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT02191306 Completed Florida State University 2014-03-31
NCT02189070 The PAtient Preference Analysis of Yearly Follow-up After PCI (PAPAYA) https://ClinicalTrials.gov/show/NCT02189070 Completed Thorax Centrum Twente 2014-08-31
NCT02188355 Prospective, Single-arm, Multi Centre Observations Ultimaster Des Registry https://ClinicalTrials.gov/show/NCT02188355 Active, not recruiting Terumo Europe N.V. 2020-06-30
NCT02186093 Clinical, Physiological and Prognostic Implication of Microvascular Status https://ClinicalTrials.gov/show/NCT02186093 Recruiting Seoul National University Hospital 2020-11-30
NCT02183454 MASCOT - Post Marketing Registry https://ClinicalTrials.gov/show/NCT02183454 Completed OrbusNeich 2017-05-31
NCT02180178 Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registery https://ClinicalTrials.gov/show/NCT02180178 Recruiting Johannes Gutenberg University Mainz 2020-09-30
NCT02137980 Registry of Non-primary Angioplasty at Hospitals Without Surgery On-site https://ClinicalTrials.gov/show/NCT02137980 Completed Johns Hopkins University 2015-12-31
NCT02131935 Impaired Peripheral Endothelial Function and In-stent Restenosis https://ClinicalTrials.gov/show/NCT02131935 Completed Kumamoto University 2013-09-30
NCT02117284 Rubidium Elution System Performance Testing https://ClinicalTrials.gov/show/NCT02117284 Completed Ottawa Heart Institute Research Corporation 2018-09-30
NCT02084888 Prognostic Impact of Chronic Total Occlusions https://ClinicalTrials.gov/show/NCT02084888 Completed Sahlgrenska University Hospital, Sweden 2012-01-31
NCT02070926 The CRONOS-ADM Registry https://ClinicalTrials.gov/show/NCT02070926 Completed Seoul St. Mary’s Hospital 2010-12-31
NCT02026466 Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion https://ClinicalTrials.gov/show/NCT02026466 Completed Saint Luke’s Health System 2017-09-30
NCT02061436 Prospective Global Registry for the Study of Chronic Total Occlusion Intervention https://ClinicalTrials.gov/show/NCT02061436 Recruiting Minneapolis Heart Institute Foundation 2020-01-31
NCT02060682 Post-Market Registry of the ACIST CPM System and Navvus Catheter in Clinical Practice https://ClinicalTrials.gov/show/NCT02060682 Completed Acist Medical Systems 2014-07-31
NCT02029092 BIOFLOW III Satellite-ELADIS Orsiro Stent System https://ClinicalTrials.gov/show/NCT02029092 Completed C.E.M. Biotronik, S.A. 2016-07-31
NCT02028728 BIOFLOW III Satellite-Italy Orsiro Stent System https://ClinicalTrials.gov/show/NCT02028728 Completed Biotronik Italia S.p.A. 2016-07-31
NCT02015832 A Trial to Evaluate a New Strategy in the Functional Assessment of 3-vessel Disease Using the SYNTAX II Score in Patients Treated With PCI https://ClinicalTrials.gov/show/NCT02015832 Active, not recruiting ECRI bv 2017-03-28
NCT01977534 To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels https://ClinicalTrials.gov/show/NCT01977534 Completed Abbott Medical Devices 2018-10-31
NCT01968499 Pharmacogenetic and Pharmacokinetic Study of Clopidogrel https://ClinicalTrials.gov/show/NCT01968499 Completed The First Affiliated Hospital with Nanjing Medical University 2017-10-17
NCT01917682 Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions https://ClinicalTrials.gov/show/NCT01917682 Completed Corindus Inc. 2016-12-31
NCT01856504 Validation of an Intracycle CT Motion CORrection Algorithm for Diagnostic AccuracY https://ClinicalTrials.gov/show/NCT01856504 Completed MDDX LLC 2015-03-31
NCT01835808 Portuguese Study on The Evaluation of FFR Guided Treatment of Coronary Disease https://ClinicalTrials.gov/show/NCT01835808 Completed Portuguese Society of Cardiology 2013-11-30
NCT01816854 Endovascular Treatment of Atherosclerotic Lesions in the SFA Using the Sinus-superflex-635 Stent https://ClinicalTrials.gov/show/NCT01816854 Completed be Medical 2017-03-29
NCT01808391 A Prospective Multicenter Post Approval Study to Evaluate the Long-term Safety and Efficacy of the Resolute Integrity in the Japanese All-comers Patients With Coronary Artery Disease (PROPEL) https://ClinicalTrials.gov/show/NCT01808391 Completed Associations for Establishment of Evidence in Interventions 2014-05-31
NCT01788592 Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry) https://ClinicalTrials.gov/show/NCT01788592 Recruiting Asan Medical Center 2030-10-31
NCT01787370 Mainz Registry of Flow-mediated Constriction https://ClinicalTrials.gov/show/NCT01787370 Completed Johannes Gutenberg University Mainz 2018-02-01
NCT01759290 ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients. https://ClinicalTrials.gov/show/NCT01759290 Completed Abbott Medical Devices 2015-08-31
NCT01759225 Registry of Cardiovascular Disease Patients https://ClinicalTrials.gov/show/NCT01759225 Enrolling by invitation Maccabi Healthcare Services, Israel 2100-12-31
NCT03349385 Registry of Secondary Revascularization https://ClinicalTrials.gov/show/NCT03349385 Active, not recruiting Hospital San Carlos, Madrid 2021-01-15
NCT02024230 Registry for Estimation of Warfarin and Rivaroxaban in Atrial Fibrillation Patients With Coronary Stent Implantation https://ClinicalTrials.gov/show/NCT02024230 Recruiting Fujita Health University 2018-12-31
NCT04444960 Precision Therapy in Complex High-risk Coronary Artery Disease https://ClinicalTrials.gov/show/NCT04444960 Recruiting First Affiliated Hospital Xi’an Jiaotong University 2023-06-30
NCT04347200 REGistry of Long-term AnTithrombotic TherApy-1 https://ClinicalTrials.gov/show/NCT04347200 Recruiting National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 2025-12-31
NCT04305171 Effect of Non-surgical Periodontal Treatment on Cardiovascular Risk Markers https://ClinicalTrials.gov/show/NCT04305171 Completed Mahidol University 2020-01-31
NCT04304677 Automated Algorithm Detecting Physiologic Major Stenosis and Its Relationship With Post-PCI Clinical Outcomes https://ClinicalTrials.gov/show/NCT04304677 Recruiting Samsung Medical Center 2020-12-31
NCT04255563 Drug-coating Balloon Treatment in Coronary Artery Disease https://ClinicalTrials.gov/show/NCT04255563 Recruiting Nanjing First Hospital, Nanjing Medical University 2030-12-30
NCT04234893 Bingo Drug-Coated Balloon in Real World https://ClinicalTrials.gov/show/NCT04234893 Recruiting Yinyi(Liaoning) Biotech Co., Ltd. 2022-09-30
NCT04198896 The Sakakibara Health Integrative Profile of Atherosclerotic-Carcinogenesis Hypothesis (SHIP-AC) https://ClinicalTrials.gov/show/NCT04198896 Completed Sakakibara Heart Institute 2019-10-31
NCT04196712 Essen Coronary Artery Disease Registry https://ClinicalTrials.gov/show/NCT04196712 Recruiting University Hospital, Essen 2022-12-30
NCT04185493 Coronary Artery Geometry and the Severity of Coronary Atherosclerosis https://ClinicalTrials.gov/show/NCT04185493 Recruiting Aristotle University Of Thessaloniki 2021-06-30
NCT04185285 Percutaneous Coronary Intervention Registry FRIBOURG https://ClinicalTrials.gov/show/NCT04185285 Recruiting University of Freiburg 2017-09-01
NCT04162561 TherApy in stabLe Coronary Artery dIsease Patients According to Clinical GuideliNes (ALIGN) https://ClinicalTrials.gov/show/NCT04162561 Active, not recruiting National Research Center for Preventive Medicine 2022-12-31
NCT04138641 Dutch Cangrelor Registry https://ClinicalTrials.gov/show/NCT04138641 Recruiting Isala 2020-07-01
NCT04087356 Age-related Macular Degeneration (AMD) and Cardiovascular Disease https://ClinicalTrials.gov/show/NCT04087356 Recruiting The New York Eye & Ear Infirmary 2020-01-31
NCT04080700 Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA) https://ClinicalTrials.gov/show/NCT04080700 Recruiting Wonju Severance Christian Hospital 2020-09-04
NCT04066062 Multicentre Registry of CCTA, IVUS and OCT https://ClinicalTrials.gov/show/NCT04066062 Recruiting Cleerly, Inc. 2021-05-31
NCT04026204 Reobtain Coronary Ostia Cannulation Beyond Transcatheter Aortic Valve Stent (RE-ACCESS) https://ClinicalTrials.gov/show/NCT04026204 Completed University of Catania 2020-01-31
NCT04025788 BIOSOLVE-IV Magmaris Swiss Satellite Registry https://ClinicalTrials.gov/show/NCT04025788 Recruiting University Hospital, Geneva 2020-12-31
NCT04014595 PREPARE-CALC-COMBO: Severely Calcified Coronary Lesions Prepared With Rotational Atherectomy and Modified Balloons https://ClinicalTrials.gov/show/NCT04014595 Recruiting Segeberger Kliniken GmbH 2020-01-31
NCT04011527 The Prospective Segeberg Registry for Rotational Atherectomy in Coronary Lesion/s https://ClinicalTrials.gov/show/NCT04011527 Recruiting Segeberger Kliniken GmbH 2030-12-31
NCT04010955 Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON) https://ClinicalTrials.gov/show/NCT04010955 Recruiting Asan Medical Center 2023-08-31
NCT04009421 Coronary Artery Plaque Burden in Stable Angina and Non-obstructive Coronary Artery Disease https://ClinicalTrials.gov/show/NCT04009421 Active, not recruiting University of Bergen 2022-01-31
NCT03999463 Sevoflurane Effect on Left Atrial Performance: A Transoesophageal Echocardiographic Study https://ClinicalTrials.gov/show/NCT03999463 Completed Ain Shams University 2019-09-30
NCT03948165 Distal Transradial Access for Coronary Angiography and Percutaneous Coronary Intervention. https://ClinicalTrials.gov/show/NCT03948165 Completed CMN “20 de Noviembre” 2018-11-30
NCT03907722 The 3q25 rs2305619 Polymorphism Associates With Microvascular Obstruction in STEMI https://ClinicalTrials.gov/show/NCT03907722 Completed Indonesian Cardiovascular Research Center 2018-08-02
NCT03852082 Predictors and Clinical Outcomes of Patients With Coronary Heart Disease Co-morbid Depression Post Percutaneous Coronary Intervention https://ClinicalTrials.gov/show/NCT03852082 Recruiting Nanjing First Hospital, Nanjing Medical University 2020-04-30
NCT03847753 Exploring the Comorbidity Between Mental Disorders and General Medical Conditions https://ClinicalTrials.gov/show/NCT03847753 Completed University of Aarhus 2016-12-31
NCT03810612 Patient-reported Outcomes After Percutaneous Coronary Intervention https://ClinicalTrials.gov/show/NCT03810612 Recruiting Haukeland University Hospital 2020-05-31
NCT03782688 Precise Percutaneous Coronary Intervention Plan (P3) Study https://ClinicalTrials.gov/show/NCT03782688 Recruiting Onze Lieve Vrouw Hospital 2020-01-15
NCT03781492 Stable Angina Management and Treatment https://ClinicalTrials.gov/show/NCT03781492 Recruiting Silesian Centre for Heart Diseases 2026-12-31
NCT03760705 Singapore Cardiac Longitudinal Outcomes Database https://ClinicalTrials.gov/show/NCT03760705 Active, not recruiting National Heart Centre Singapore 2025-12-31
NCT03737565 Evaluation of the Safety and Efficacy of Titanium-nitric Oxide-coated Stent (Optimax®) in Patients With Lesions With a Low Risk of Restenosis (Diameter ≥ 3.0 mm and Length ≤ 20 mm) https://ClinicalTrials.gov/show/NCT03737565 Recruiting Fundación EPIC 2020-01-15
NCT03709693 Clinical Outcomes in Patients Treated With SternaLock Blu https://ClinicalTrials.gov/show/NCT03709693 Recruiting Zimmer Biomet 2026-01-01
NCT03691688 The Long Term Effect of Low Dose Aspirin on Uric Acid in Chinese Patients With Coronary Artery Disease(AURORA) https://ClinicalTrials.gov/show/NCT03691688 Recruiting Shanghai Zhongshan Hospital 2021-11-01
NCT03651180 Efficacy and Safety of Coronary Amphilimus-ELuting Stent in diAbeTic patiEnts https://ClinicalTrials.gov/show/NCT03651180 Active, not recruiting Ospedale S. Giovanni Bosco 2020-10-01
NCT03619395 Risc Optimisation- Acute cor5onary Syndrome https://ClinicalTrials.gov/show/NCT03619395 Recruiting Parc de Salut Mar 2020-07-01
NCT03567733 Prospective Registry of Patients Over 75 Years Old Treated With Xience Sierra Stents. Sierra 75 Study https://ClinicalTrials.gov/show/NCT03567733 Active, not recruiting Fundación EPIC 2019-12-01
NCT03544294 veRy Thin Stents for Patients With Left mAIn or bifurcatioN in Real Life: the RAIN a Multicenter Study https://ClinicalTrials.gov/show/NCT03544294 Completed Azienda Ospedaliera Città della Salute e della Scienza di Torino 2018-05-30
NCT03531151 MRI of Myocardial Infarction https://ClinicalTrials.gov/show/NCT03531151 Recruiting University of Pennsylvania 2023-03-31
NCT03518437 Coronary Atherosclerosis Disease Early Identification and Risk Stratification by Noninvasive Imaging https://ClinicalTrials.gov/show/NCT03518437 Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital 2019-09-30
NCT03509532 DRUG ELUTING STENT FOR DIABETIC PATIENTS IN CORONARY ARTERY DISEASE TREATMENT https://ClinicalTrials.gov/show/NCT03509532 Recruiting Istituto Clinico Sant’Ambrogio 2019-01-31
NCT03507205 Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents https://ClinicalTrials.gov/show/NCT03507205 Completed Seoul National University Hospital 2017-11-01
NCT03475563 BiOSS Study (BiOSS LIM C Stent Registry in Bifurcated Lesions) https://ClinicalTrials.gov/show/NCT03475563 Recruiting Hospital Universitari Vall d’Hebron Research Institute 2019-12-30
NCT03471234 Latin America Real World Study With Inspiron Drug Eluting Stent - INSPIRON LATITUDE https://ClinicalTrials.gov/show/NCT03471234 Recruiting Scitech Produtos Medicos Ltda 2020-06-30
NCT03461367 CTO Registry From Insight of IVUS in Fuwai Hospital https://ClinicalTrials.gov/show/NCT03461367 Recruiting China National Center for Cardiovascular Diseases 2019-12-31
NCT03462277 DNA Methylation and Hydroxymethylation Levels in Patients With Coronary Heart Disease https://ClinicalTrials.gov/show/NCT03462277 Completed Chongqing Medical University 2018-08-01
NCT03444259 Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients https://ClinicalTrials.gov/show/NCT03444259 Recruiting University of Turku 2025-12-31
NCT03443999 S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System https://ClinicalTrials.gov/show/NCT03443999 Recruiting Sahajanand Medical Technologies Pvt. Ltd. 2022-06-30
NCT03438448 Perioperative Myocardial Ischemia: Troponin Monitoring,Cost-effectiveness, Insights Into Pathophysiology https://ClinicalTrials.gov/show/NCT03438448 Recruiting Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2019-12-31
NCT03428048 Cardiovascular Innovation & Research Institute ’s NEXUS Registry, the Whole is Greater Than the Parts. https://ClinicalTrials.gov/show/NCT03428048 Recruiting Cardiovascular Innovation and Research Institute 2026-03-31
NCT03427749 Multi-Center Evaluation of Feasibility of SPECT Measurement of Myocardial Blood Flow and Reserve https://ClinicalTrials.gov/show/NCT03427749 Recruiting Ottawa Heart Institute Research Corporation 2020-09-30
NCT03413813 Registry of Patients With a Bioabsorbable Magnesium Stent Implant MAGMARIS in Usual Clinical Practice https://ClinicalTrials.gov/show/NCT03413813 Active, not recruiting Spanish Society of Cardiology 2021-05-31
NCT03870087 PRECISION GRX Post-Market Study - Japan https://ClinicalTrials.gov/show/NCT03870087 Recruiting Corindus Inc. 2020-10-31
NCT03362788 The Greek AntiPlatElet Atrial Fibrillation Registry. https://ClinicalTrials.gov/show/NCT03362788 Recruiting Attikon Hospital 2020-06-30
NCT01094275 Role of CYP2C19 Polymorphism in the Drug Interaction Between Clopidogrel and Omeprazole https://ClinicalTrials.gov/show/NCT01094275 Completed The Methodist Hospital System 2014-06-30
NCT03767621 Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR https://ClinicalTrials.gov/show/NCT03767621 Recruiting Fundación EPIC 2025-06-30
NCT03745066 BioFreedom French Registry https://ClinicalTrials.gov/show/NCT03745066 Active, not recruiting Biosensors Europe SA 2021-04-30
NCT03045848 Biofreedom Prospective Multicenter Observational Registry https://ClinicalTrials.gov/show/NCT03045848 Recruiting Wonju Severance Christian Hospital 2020-06-30
NCT02929030 Clinical Performance of Nano Plus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease https://ClinicalTrials.gov/show/NCT02929030 Recruiting Xijing Hospital 2018-01-31
NCT03788512 Coexistence of Cerebral and Coronary Atherosclerosis in Acute Ischemic Cerebrovascular Disease Patients Registry https://ClinicalTrials.gov/show/NCT03788512 Recruiting Xuanwu Hospital, Beijing 2022-01-12
NCT01850693 Assessment of Coronary Artery Disease in Stroke Patients https://ClinicalTrials.gov/show/NCT01850693 Completed Seoul National University Hospital 2012-12-31
NCT03890822 Coronary Artery Disease Progression in Patients With Acute Coronary Syndromes and Diabetes Mellitus https://ClinicalTrials.gov/show/NCT03890822 Recruiting Humanitas Hospital, Italy 2022-03-25